Dyadic International Inc.

Company Overview

Dyadic International, founded in 1979, is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries.

The company has patented and proprietary C1 platform technology based on a unique fungal microorganism that is programmable and scalable in producing enzymes and proteins in large quantities. Dyadic’s C1 platform technology is effective in producing enzymes from a broad variety of feedstocks that can be used to produce many types of biofuels including, but not limited to, cellulosic ethanol, biobutanol and biodiesel.

Financial Highlights (FY 2024)

Company's Business Segments

• Microbial Platforms : The company provides microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for affordable, effective, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative proteins.